The American Kratom Association (AKA) today issued a nationwide Consumer Alert warning consumers, regulators, and public health officials about the growing proliferation of dangerous products containing 7-hydroxymitragynine (7-OH) and other synthetic/semi-synthetic products that are being falsely marketed as “kratom.”
According to the AKA, these products bear little resemblance to natural kratom leaf and instead represent a new category of chemically manipulated, highly concentrated compounds that pose significantly greater safety risks to consumers.
“Consumers deserve to know the truth,” said AKA Senior Fellow on Public Policy Mac Haddow. “These 7-OH products are not traditional kratom. They are being engineered, concentrated, and marketed in ways that create risks that are not associated with natural kratom leaf.”
A Stark Scientific and Regulatory Distinction
Natural kratom leaf contains only trace levels of 7-OH formed through natural post-harvest oxidation. In contrast, the products highlighted in this Consumer Alert often contain artificially elevated concentrations of 7-OH, frequently delivered through high-risk formats that now include sublingual strips and dissolvable tablets that go right to the consumer’s bloodstream to target mu-opioid receptors.
These delivery systems are designed to bypass normal metabolic processes, rapidly delivering potent concentrations into the bloodstream.
Federal health officials have already drawn a clear line between these substances. During a July 29, 2025, joint announcement, U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) leadership emphasized that chemically manipulated 7-OH products are fundamentally different from natural kratom leaf. This is a distinction described by FDA Commissioner Marty Makary as “like night and day.”
Consumer Deception and Public Health Risk
The AKA warns that many 7-OH products are mislabeled as “kratom”, misleading consumers, packaged in child-appealing forms, marketed with unsubstantiated claims for pain relief or mood enhancement, and sold without adequate safety data or labeling standards
This has created widespread confusion among consumers and policymakers, with some legislative efforts mistakenly targeting natural kratom products rather than the actual source of emerging risk: synthetic or chemically enhanced 7-OH compounds.
“This is not a debate about kratom,” Haddow added. “This is about stopping a new class of unregulated, opioid-like substances from being disguised as something they are not.”
Call for Targeted Regulatory Action
The AKA is calling on federal and state regulators to take immediate, targeted action to protect consumers:
• Ban or schedule chemically manipulated 7-OH and its analogs
• Prohibit the marketing of 7-OH products as “kratom”
• Enforce strict labeling and safety standards
• Preserve legal access to natural kratom leaf products under Kratom Consumer Protection Acts (KCPA)
Protecting Consumers Through Truth and Transparency
The Consumer Alert is part of a broader initiative to combat what the AKA describes as a growing wave of misinformation and deceptive marketing practices that threaten both consumer safety and informed policymaking.
“If regulators fail to act with precision, they risk banning safe products while leaving truly dangerous ones in the marketplace,” Haddow said. “We must get this right.”
